Form 4: Tivic Health Systems CEO Jennifer Ernst Awarded 500,000 Restricted Stock Units

Tivic Health Systems' CEO, Jennifer Ernst, received 500,000 restricted stock units (RSUs) on December 18, 2024, which vest over a three-year period.

Summary

• Jennifer Ernst, CEO of Tivic Health Systems, was granted 500,000 restricted stock units (RSUs) on December 18, 2024.
• The RSUs are convertible into shares of common stock on a 1:1 basis.
• The vesting schedule is as follows: 50% vests on the one-year anniversary of the Vesting Commencement Date, and the remaining 50% vests in eight equal quarterly installments over the subsequent two years.
• The RSUs expire on December 17, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and aligns management's interests with shareholders. The vesting schedule promotes long-term commitment.

Positives

• The grant of RSUs to the CEO aligns her interests with those of the shareholders, incentivizing her to drive long-term value creation.
• The vesting schedule encourages continued service and commitment from the CEO over the next three years.

Future Outlook

The vesting schedule suggests a commitment to the company's future performance over the next three years.

Industry Context

Granting stock-based compensation is a common practice to align executive incentives with shareholder value in the health systems industry.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the CEO's interests with the company's long-term success.
• Employees may see the RSU grant as a sign of confidence in the company's future.

Key Dates

Keywords

Restricted Stock Units, RSU, Jennifer Ernst, Tivic Health Systems, Executive Compensation, Beneficial Ownership, Form 4